S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/BVF Partners/Q1 2021

BVF Partners

Period: Q1 2021 Β· Filed: 2021-05-17
View on SEC EDGAR β†—
AUM
$2.67B
Total portfolio value
Positions
67
Reported securities
Top Holding
FPRX
8.9% $238.8M
QoQ Changes
+8 / -8
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2021-05-17) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
FPRXFIVE PRIME THERAPEUTICS INC$238.8M8.95%β€”β€”
8.9%
OLMAOLEMA PHARMACEUTICALS INC$221.0M8.29%$33.18$12.64-61.9%
8.3%
MRUSMERUS N V$152.2M5.71%β€”β€”
5.7%
XOMAXOMA CORP DEL$144.1M5.40%$40.81$43.00+5.4%
5.4%
RVMDREVOLUTION MEDICINES INC$135.0M5.06%$45.88$189.24+312.5%
5.1%
RPTXREPARE THERAPEUTICS INC$114.2M4.28%β€”β€”
4.3%
PTGXPROTAGONIST THERAPEUTICS INC$102.5M3.84%$25.90$131.62+408.2%
3.8%
KYMRKYMERA THERAPEUTICS INC$102.2M3.83%$38.86$113.51+192.1%
3.8%
RLAYRELAY THERAPEUTICS INC$99.3M3.72%$34.57$18.65-46.0%
3.7%
ARGXARGENX SE$85.3M3.20%$275.39$939.68+241.2%
3.2%
EPIXESSA PHARMA INC$84.5M3.17%β€”β€”
3.2%
XENEXENON PHARMACEUTICALS INC$62.3M2.34%$17.90$60.96+240.6%
2.3%
IONSIONIS PHARMACEUTICALS INC$61.4M2.30%$44.96$81.80+81.9%
2.3%
IDYAIDEAYA BIOSCIENCES INC$61.3M2.30%$23.50$37.65+60.2%
2.3%
ACIUAC IMMUNE SA$57.1M2.14%$7.61$2.51-67.0%
2.1%
RCUSARCUS BIOSCIENCES INC$52.7M1.98%$28.08$30.33+8.0%
2.0%
LXRXLEXICON PHARMACEUTICALS INC$49.3M1.85%$5.87$2.32-60.5%
1.9%
KURAKURA ONCOLOGY INC$46.2M1.73%$28.27$11.10-60.7%
1.7%
IKNAIKENA ONCOLOGY INC$45.2M1.69%β€”β€”
1.7%
FDMT4D MOLECULAR THERAPEUTICS IN$44.7M1.68%$43.38$13.00-70.0%
1.7%
CGEMCULLINAN ONCOLOGY INC$43.7M1.64%$41.67$17.63-57.7%
1.6%
CTMXCYTOMX THERAPEUTICS INC$43.1M1.62%$7.73$3.82-50.6%
1.6%
MTEMXXXXMOLECULAR TEMPLATES INC$36.1M1.36%β€”β€”
1.4%
SPROSPERO THERAPEUTICS INC$31.5M1.18%$14.72$2.20-85.0%
1.2%
GLYCGLYCOMIMETICS INC$28.7M1.08%β€”β€”
1.1%
VIRXVIRACTA THERAPEUTICS INC$28.6M1.07%β€”β€”
1.1%
VSTMXXXXVERASTEM INC$28.4M1.06%β€”β€”
1.1%
INFIQINFINITY PHARMACEUTICALS INC$27.1M1.02%$3.23$0.00
1.0%
OVIDOVID THERAPEUTICS INC$25.8M0.97%$4.02$2.69-33.1%
1.0%
ANABANAPTYSBIO INC$25.6M0.96%$14.37$63.42+341.3%
1.0%

Quarter-on-Quarter Activity

Q1 2021 vs. Q4 2020

New Positions (8)

TickerIssuerNotionalSince Filing
IKNAIKENA ONCOLOGY INC$45.2M
CGEMCULLINAN ONCOLOGY INC$43.7M-57.7%
VIRXVIRACTA THERAPEUTICS INC$28.6M
ANABANAPTYSBIO INC$25.6M+341.3%
SLNSILENCE THERAPEUTICS PLC$15.8M
ANGNANGION BIOMEDICA CORP$15.8M
REPLREPLIMUNE GROUP INC$14.1M
ELDNELEDON PHARMACEUTICALS INC$11.9M

Exited Positions (8)

TickerIssuerNotional
CYTKCYTOKINETICS INC$101.4M
XNCRXENCOR INC$55.2M
ALXOALX ONCOLOGY HLDGS INC$46.6M
NVUSNOVUS THERAPEUTICS INC$11.8M
GMDAQGAMIDA CELL LTD$11.3M
CRISCURIS INC$5.1M
PHATPHATHOM PHARMACEUTICALS INC$5.0M
RGLSREGULUS THERAPEUTICS INC$4.6M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
FPRXFIVE PRIME THERAPEUTICS INC$221.1M+510.3%
ARGXARGENX SE$66.9M+395.4%+241.2%
CFRXCONTRAFECT CORP$10.2M+138.3%
IMVTIMMUNOVANT INC$-5.4M+122.4%
CRVSCORVUS PHARMACEUTICALS INC$3.0M+66.1%
OVIDOVID THERAPEUTICS INC$15.3M+41.9%-33.1%
XFORXXXXX4 PHARMACEUTICALS INC$4.3M+37.7%
MTEMXXXXMOLECULAR TEMPLATES INC$16.0M+33.3%

Trimmed (8)

TickerIssuerNotionalShares Ξ”Since Filing
AMRNXXXXAMARIN CORP PLC$-42.0M-84.1%
SNDXSYNDAX PHARMACEUTICALS INC$-15.9M-81.4%
STROSUTRO BIOPHARMA INC$-21.4M-55.4%
INFIQINFINITY PHARMACEUTICALS INC$-9.9M-51.9%
RCUSARCUS BIOSCIENCES INC$-18.8M-31.8%+8.0%
GRTSQGRITSTONE ONCOLOGY INC$6.9M-30.9%
RNACSELECTA BIOSCIENCES INC$0.8M-28.0%
ACIUAC IMMUNE SA$6.4M-23.6%-67.0%
← Back to Hedge Funds